JPH0362711B2 - - Google Patents

Info

Publication number
JPH0362711B2
JPH0362711B2 JP63152471A JP15247188A JPH0362711B2 JP H0362711 B2 JPH0362711 B2 JP H0362711B2 JP 63152471 A JP63152471 A JP 63152471A JP 15247188 A JP15247188 A JP 15247188A JP H0362711 B2 JPH0362711 B2 JP H0362711B2
Authority
JP
Japan
Prior art keywords
compound
formula
group
acid
syn isomer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP63152471A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6425768A (en
Inventor
Eemu Rune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Roussel Uclaf SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR7708988A external-priority patent/FR2384782A1/fr
Priority claimed from FR7736512A external-priority patent/FR2421906A2/fr
Application filed by Roussel Uclaf SA filed Critical Roussel Uclaf SA
Publication of JPS6425768A publication Critical patent/JPS6425768A/ja
Publication of JPH0362711B2 publication Critical patent/JPH0362711B2/ja
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/587—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with aliphatic hydrocarbon radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms, said aliphatic radicals being substituted in the alpha-position to the ring by a hetero atom, e.g. with m >= 0, Z being a singly or a doubly bound hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
JP63152471A 1977-03-25 1988-06-22 2-(2-amino-4-thiazolyl)-2-methoxyiminoacetic acid derivative and manufacture Granted JPS6425768A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR7708988A FR2384782A1 (fr) 1977-03-25 1977-03-25 Nouvelles oximes derivees de l'acide 3-acetoxymethyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR7736512A FR2421906A2 (fr) 1977-12-05 1977-12-05 Nouvelles oximes derivees de l'acide 3-acetoxy methyl 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments

Publications (2)

Publication Number Publication Date
JPS6425768A JPS6425768A (en) 1989-01-27
JPH0362711B2 true JPH0362711B2 (en, 2012) 1991-09-26

Family

ID=26219930

Family Applications (2)

Application Number Title Priority Date Filing Date
JP3319378A Granted JPS53119887A (en) 1977-03-25 1978-03-24 Novel oxime derivative of 33acetoxymethyll 77aminothiazolylacetoamide cephalospolanate process for preparing same and pharmaceutical composition
JP63152471A Granted JPS6425768A (en) 1977-03-25 1988-06-22 2-(2-amino-4-thiazolyl)-2-methoxyiminoacetic acid derivative and manufacture

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP3319378A Granted JPS53119887A (en) 1977-03-25 1978-03-24 Novel oxime derivative of 33acetoxymethyll 77aminothiazolylacetoamide cephalospolanate process for preparing same and pharmaceutical composition

Country Status (18)

Country Link
US (4) US4288434A (en, 2012)
JP (2) JPS53119887A (en, 2012)
AT (1) AT360153B (en, 2012)
AU (1) AU520657B2 (en, 2012)
CA (1) CA1125280A (en, 2012)
CH (4) CH648555A5 (en, 2012)
DE (2) DE2812625A1 (en, 2012)
DK (1) DK159156C (en, 2012)
ES (2) ES468169A1 (en, 2012)
GB (2) GB1605176A (en, 2012)
HU (1) HU182567B (en, 2012)
IE (1) IE47361B1 (en, 2012)
IT (1) IT1103478B (en, 2012)
LU (1) LU79312A1 (en, 2012)
NL (1) NL192041C (en, 2012)
PH (1) PH15764A (en, 2012)
PT (1) PT67815A (en, 2012)
SE (2) SE439312B (en, 2012)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE878514A (fr) * 1978-09-04 1980-02-29 Fujisawa Pharmaceutical Co Procede de preparation de composes d'acide 3-cephem-4-carboxylique a disubstitution en positions 3 et 7, nouveaux produits ainsi obtenus et leur utilisation pour leur activite antibacterienne
US4409217A (en) 1977-03-14 1983-10-11 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra
FR2410655A1 (fr) * 1977-12-05 1979-06-29 Roussel Uclaf Nouvelles oximes derivees de l'acide 3-substitue 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2432521A1 (fr) * 1978-03-31 1980-02-29 Roussel Uclaf Nouvelles oximes o-substituees derivees de l'acide 7-amino thiazolyl acetamido cephalosporanique, leur procede de preparation et leur application comme medicaments
FR2421907A1 (fr) * 1978-04-07 1979-11-02 Roussel Uclaf Nouvelles cephalosporines derivees de l'acide 7-/2-(2-amino 4-thiazolyl)2-(carboxymethoxyimino/acetamido 3-substitue cephalosporanique, leur procede de preparation et leur application comme medicaments
DE2967356D1 (en) 1978-07-17 1985-02-28 Fujisawa Pharmaceutical Co Cephalosporin derivatives, process for their preparation and pharmaceutical compositions containing them
US4372952A (en) 1978-07-31 1983-02-08 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4284631A (en) * 1978-07-31 1981-08-18 Fujisawa Pharmaceutical Co., Ltd. 7-Substituted cephem compounds and pharmaceutical antibacterial compositions containing them
US4341775A (en) * 1978-09-11 1982-07-27 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
DE2945248A1 (de) * 1978-11-13 1980-05-22 Fujisawa Pharmaceutical Co Cephem-verbindungen, verfahren zu ihrer herstellung und sie enthaltende antibakterielle pharmazeutische mittel
US4237128A (en) 1979-04-12 1980-12-02 E. R. Squibb & Sons, Inc. 7-[2-(2-Amino-4-thiazolyl)-2-[(1-carboxy-1,1-dialkyl)alkoxyimino]acetamido]cephem sulfoxides
BE885487A (fr) * 1979-10-02 1981-04-01 Glaxo Group Ltd Nouvelles cephalosporines et leur preparation
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
CH642957A5 (de) 1980-02-18 1984-05-15 Lonza Ag Verfahren zur herstellung von (2-aminothiazol-4-yl)-essigsaeure-hydrochlorid.
US4252802A (en) * 1980-03-13 1981-02-24 E. R. Squibb & Sons, Inc. Hydroxamic acid derivatives of 7-[(2-amino-4-thiazolyl)-oximino] cephalosporins
GR76342B (en, 2012) * 1981-02-02 1984-08-06 Fujisawa Pharmaceutical Co
EP0058250A3 (de) * 1981-02-17 1983-08-17 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Cephalosporinderivate, deren Herstellung und entsprechende pharmazeutische Präparate
IE53429B1 (en) * 1981-08-03 1988-11-09 Fujisawa Pharmaceutical Co New cephem compounds and processes for preparation thereof
ATE14728T1 (de) * 1981-11-13 1985-08-15 Glaxo Group Ltd Thiazol-derivate und ihre verwendung bei der herstellung von beta-lactam-antibiotika.
DE3269474D1 (en) * 1981-11-13 1986-04-03 Glaxo Group Ltd Thiazole derivatives and their use in the manufacture of beta-lactam antibiotics
ATE30724T1 (de) 1982-06-28 1987-11-15 Bristol Myers Co Cephalosporinderivate, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen die sie enthalten.
EP0115770B2 (en) * 1983-01-07 1996-06-19 Takeda Chemical Industries, Ltd. Thiazole Derivatives
US4652651A (en) * 1983-05-31 1987-03-24 Hoffmann-La Roche Inc. Process for the manufacture of 1-sulpho-2-oxoazetidine carboxylic acid intermediates via catalytic ester cleavage
DE150507T1 (de) * 1983-12-29 1987-02-26 Mochida Pharmaceutical Co., Ltd., Tokio/Tokyo Cephalosporinverbindungen, verfahren zu ihrer herstellung und pharmazeutishe praeparate.
AT381496B (de) * 1984-04-10 1986-10-27 Biochemie Gmbh Verfahren zur herstellung von cephalosporinantibiotika
US4610824A (en) * 1984-10-09 1986-09-09 E. R. Squibb & Sons, Inc. Hydrazide derivatives of monocyclic beta-lactam antibiotics
US4680409A (en) * 1984-10-09 1987-07-14 E. R. Squibb & Sons, Inc. Hydrazide containing derivatives of 2-amino-4-thiazole-acetic acid
US4840945A (en) * 1985-04-01 1989-06-20 Mochida Pharmaceutical Co., Ltd. Cephalosporin derivatives
US4647660A (en) * 1985-05-02 1987-03-03 E. R. Squibb & Sons, Inc. 3-acylamino-2-oxo-1-azetidinesulfonic acids
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
CN1313452C (zh) * 2005-06-08 2007-05-02 浙江普洛化学有限公司 制备(z)－2－(2－氨基－4－噻唑)－2－羟基亚胺乙酸酯及其衍生物的方法

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3971778A (en) * 1972-05-12 1976-07-27 Glaxo Laboratories Limited Cephalosporins having (α-etherified oximino)acylamido groups at the 7-position
GB1399086A (en) * 1971-05-14 1975-06-25 Glaxo Lab Ltd Cephalosporin compounds
GB1472534A (en) * 1973-07-06 1977-05-04 Glaxo Lab Ltd 7beta-hydroxyiminoacylamido-cephalosporins
DK674674A (en, 2012) * 1973-12-21 1975-09-08 Glaxo Lab Ltd
US4144393A (en) * 1973-12-21 1979-03-13 Glaxo Laboratories Limited 3-Acetoxymethyl cephalosporins having at position-7 a carboxy substituted α-etherified hydroxyiminoarylacetamido group
DK154939C (da) * 1974-12-19 1989-06-12 Takeda Chemical Industries Ltd Analogifremgangsmaade til fremstilling af thiazolylacetamido-cephemforbindelser eller farmaceutisk acceptable salte eller estere deraf
US4203899A (en) * 1974-12-19 1980-05-20 Takeda Chemical Industries, Ltd. Thiazolylacetamido compounds
DE2760123C2 (de) * 1976-01-23 1986-04-30 Roussel-Uclaf, Paris 7-Aminothiazolyl-syn-oxyiminoacetamidocephalosporansäuren, ihre Herstellung und sie enthaltende pharmazeutische Zusammensetzungen
US4376203A (en) * 1976-01-23 1983-03-08 Roussell Uclaf Novel 3-acetoxymethyl-7-(iminoacetamido)-cephalosporanic acid derivatives
GB1576625A (en) * 1976-04-12 1980-10-08 Fujisawa Pharmaceutical Co Syn isomer 3,7 disubstituted 3 cephem 4 carboxylic acid compounds and processes for the preparation thereof
US4166115A (en) * 1976-04-12 1979-08-28 Fujisawa Pharmaceutical Co., Ltd. Syn 7-oxoimino substituted derivatives of cephalosporanic acid
DK162391C (da) * 1976-04-12 1992-03-09 Fujisawa Pharmaceutical Co Analogifremgangsmaade til fremstilling af syn-isomerer af 3,7-disubstituerede 3-cephem-4-carboxylsyreforbindelser
JPS6011713B2 (ja) * 1976-09-08 1985-03-27 武田薬品工業株式会社 セフアロスポリン誘導体およびその製造法
PH17188A (en) * 1977-03-14 1984-06-14 Fujisawa Pharmaceutical Co New cephem and cepham compounds and their pharmaceutical compositions and method of use
SE439312B (sv) * 1977-03-25 1985-06-10 Roussel Uclaf Sett att framstella nya oximderivat av 3-acetoximetyl-7-aminotiazolylacetamido cefalosporansyra

Also Published As

Publication number Publication date
IE47361B1 (en) 1984-03-07
DK129578A (da) 1978-09-26
NL7803166A (nl) 1978-09-27
US4288434A (en) 1981-09-08
IE780604L (en) 1978-09-25
DE2812625A1 (de) 1978-09-28
IT7848604A0 (it) 1978-03-24
AU520657B2 (en) 1982-02-18
GB1605176A (en) 1982-11-17
SE8304239L (sv) 1983-08-02
CH639652A5 (fr) 1983-11-30
CH633292A5 (fr) 1982-11-30
SE8304239D0 (sv) 1983-08-02
SE439312B (sv) 1985-06-10
CA1125280A (fr) 1982-06-08
SE453192B (sv) 1988-01-18
GB1605175A (en) 1982-11-17
NL192041C (nl) 1997-01-07
AU3447178A (en) 1979-09-27
AT360153B (de) 1980-12-29
DE2858771C2 (en, 2012) 1990-09-06
CH646159A5 (fr) 1984-11-15
JPS53119887A (en) 1978-10-19
DK159156B (da) 1990-09-10
DK159156C (da) 1991-02-11
JPS6425768A (en) 1989-01-27
US4487937A (en) 1984-12-11
ES477592A1 (es) 1979-08-01
SE7802833L (sv) 1978-11-02
PT67815A (fr) 1978-04-01
US4386210A (en) 1983-05-31
ATA218378A (de) 1980-05-15
NL192041B (nl) 1996-09-02
US4483981A (en) 1984-11-20
ES468169A1 (es) 1979-07-16
IT1103478B (it) 1985-10-14
PH15764A (en) 1983-03-24
DE2812625C2 (en, 2012) 1990-08-23
HU182567B (en) 1984-02-28
CH648555A5 (fr) 1985-03-29
LU79312A1 (fr) 1978-11-03
JPS6237037B2 (en, 2012) 1987-08-10

Similar Documents

Publication Publication Date Title
JPH0362711B2 (en, 2012)
DE2760287C2 (en, 2012)
JPH0313237B2 (en, 2012)
JPH0257072B2 (en, 2012)
JPS5834474B2 (ja) チアゾリジン誘導体の製造法
JPH02311483A (ja) セフトリアキソンの製造方法
JPH0730018B2 (ja) 新規化合物の３−アミノ−２−オキソアゼチジン誘導体及びそれらの製造法
JP2825655B2 (ja) ３−セフェム−４−カルボン酸誘導体の精製方法
JPS638107B2 (en, 2012)
FR2517308A1 (fr) Procede de preparation de derives de 3-alcoxymethylcephalosporines
JPS6360992A (ja) ３−置換７−アミノチアゾリルアセトアミドセフアロスポラン酸の新規なオキシム誘導体
US4935508A (en) Process for cephem prodrug esters
US3962272A (en) 1h-tetrazole-1-acetate esters and acids and process therefor
JPS61218580A (ja) ２−（２−アミノ−４−チアゾリル）−２−メトキシイミノ酢酸誘導体及びその製造法
FR2482104A1 (fr) Procede de preparation de cefuroxime de sodium et solvate de cefuroxime de sodium et de tetrahydrofuranne obtenu par ce procede
JPH0247473B2 (en, 2012)
JPH01175956A (ja) 光学的に純粋な３−ヒドロキシ酸類の精製法
JPS6129957B2 (en, 2012)
SU953983A3 (ru) Способ получени производных цефалоспорина
JPS6322585A (ja) ６−トリフルオロメチル−１ｈ−ベンゾトリアゾ−１−イル−ジフェニルホスフェイト及びセファロスポリン誘導体の製造方法
FR2501685A1 (fr) Nouveaux derives du pyrazole
US3178426A (en) 1, 3, 4-dioxazolyl-cephalosporin derivatives
US4029656A (en) 7-(α-SULFOACYLAMIDO) CEPHALOSPORANIC ACIDS
US3681370A (en) Certain acyloxy thiazolidines and process for their manufacture
FR2563831A1 (fr) Nouveaux derives de thienopyridinone, leur procede de preparation et compositions pharmaceutiques les contenant